SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-15-000206
Filing Date
2015-05-11
Accepted
2015-05-11 16:22:35
Documents
9
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nnab-20150331_10q.htm 10-Q 211554
2 EXHIBIT 31.1 nnab-20150331_10qex31z1.htm EX-31.1 12128
3 EXHIBIT 32.1 nnab-20150331_10qex32z1.htm EX-32.1 5680
  Complete submission text file 0001520138-15-000206.txt   1344808

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE nnab-20150331.xml EX-101.INS 121104
5 XBRL SCHEMA FILE nnab-20150331.xsd EX-101.SCH 13028
6 XBRL CALCULATION FILE nnab-20150331_cal.xml EX-101.CAL 18603
7 XBRL DEFINITION FILE nnab-20150331_def.xml EX-101.DEF 14739
8 XBRL LABEL FILE nnab-20150331_lab.xml EX-101.LAB 96335
9 XBRL PRESENTATION FILE nnab-20150331_pre.xml EX-101.PRE 70401
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 3055154118
NANOANTIBIOTICS, INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 15851040
SIC: 2834 Pharmaceutical Preparations